Clinical Trial Update: STRIBILD in Non-Nucleoside Resistant Patients (SINNR STUDY)

View source ↗

Summary

A clinical trial update for STRIBILD in HIV patients who are resistant to non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: Vancouver Infectious Diseases Centre | Conditions: HIV, Illicit Drug User | Status: UNKNOWN